Tag Archive for: Frazier

point-normal-V_VLNr6qtn4-unsplashUnsplash+
Financing

Immutrin secures £65m Series A for amyloid-removing heart therapy

Immutrin, a UK biotech, has raised £65m (€75m) in Series A funding for a pioneering antibody designed to remove pre-existing amyloid deposits in amyloidosis.

Read more
Dual payload ADCHummingbird Bioscience
Financing

ADC maker Callio Therapeutics secures US$187m in Series A round

Investment company Frazier Life Sciences has launched the virtual ADC company Callio Therapeutics Inc by licencing Hummingbird Bioscience’s TopDDRive dual payload ADC technology and co-leading a US$187m financing round with French Jeito Capital and other investors.

Read more